UnitedHealth Group Incorporated (UNH)
Return on equity (ROE)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 14,405,000 | 22,381,000 | 20,120,000 | 17,285,000 | 15,403,000 |
| Total stockholders’ equity | US$ in thousands | 92,658,000 | 88,756,000 | 77,772,000 | 71,760,000 | 65,491,000 |
| ROE | 15.55% | 25.22% | 25.87% | 24.09% | 23.52% |
December 31, 2024 calculation
ROE = Net income ÷ Total stockholders’ equity
= $14,405,000K ÷ $92,658,000K
= 15.55%
UnitedHealth Group Incorporated has shown a generally positive trend in return on equity (ROE) over the past five years. The ROE increased steadily from 23.52% as of December 31, 2020, to 24.09% by December 31, 2021, and further improved to 25.87% by the end of 2022. However, there was a slight decrease in ROE to 25.22% by December 31, 2023. The most significant decline in ROE was observed by the end of 2024, where the ROE dropped to 15.55%.
Overall, the ROE performance of UnitedHealth Group Incorporated demonstrates a strong financial performance, indicating the company's ability to generate profit from its shareholders' equity. Despite the decline in ROE in the most recent year, the company has maintained relatively healthy returns compared to industry benchmarks. Further analysis of the company's financial activities and strategies may be necessary to understand the factors contributing to the fluctuations in ROE.
Peer comparison
Dec 31, 2024